3[3]Pravinkumar E,Webster NR.HIT/HITT and alternative anticoagulation[J].Current Concepts, Br J Anaesth,2003,90(5),676-685.
4[5]Linda.Shore-Lesserson.New anticoagulants agents[J].Canadina Journal of Anesthesia,2004,51:R9.
5[6]Dan Longrosis,Emmanuel de Maistre,Nicolas Bischiff,et al.Recobmint hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia[J].Canadian Jounral of Anesthesia,2000,47:255-260.
6[7]Kunt Tove Lappegard,Michael Fung,Grethe Bergseth,et al.Artificial Surface-induced Cytokine Synthesis:erect of hepar in Coating and Complement inhibition[J].Ann Thorac Surg,2004,78:34-38.
7[8]Matsuo T Koide M,Kario K.Application of argatroban,direct thrombin inhibitor,in heparin-intolerant patients requiring extracorporeal[J].Arlif organ,1977,21(9)1035-1038.
9[10]Walker CPR,Royston D.Thrombin generation and its inhibition:a review of the scientific basic and mechanism of action of anticoagulant therapies[J].Br J Anaesth,2002,88(6):848-863.
二级参考文献18
1[1]Boyle EM, Pohlman TH, Johnson MC, et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response[J]. Ann Thorac Surg,1997 ,63 :277 -284.
2[2]Boisclair MD, Lane DA, Philippou H, et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass[J]. Blood, 1993,82:3350 - 3357.
3[3]Verrier ED, Morgan EN. Endothelial response to cardiopulmonary bypass surgery [J]. Ann Thorac Surg, 1998,66: S17-S19.
4[4]Cicala C, Cirino G. Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk[J]. Life Sci, 1998,62:1817 - 1824.
5[5]Asimakopoulos G, Taylor KM. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules[J]. Ann Thorac Surg, 1998,66:2135 - 2144.
6[6]Daane C, Golab H, Meeder J, et al. Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume[J]. Perfusion. 2003 Apr; 18 (2): 115-121.
7[7]Parratt R, Hunt BJ. Direct activation of factor X by monocytes occurs during cardiopulmonary bypass [J]. Br J Haematol,1998,101:40 -46.
8[8]Mariani MA, Gu YJ, Boonstra PW, et al. Procoagulant activity after off - pump coronary operation: is the current anticoagulation adequate [J]. Ann Thorac Surg, 1999,67:1370 - 1375.
9[9]Mannucci L, Gerometta PS, Mussoni L, et al. One month follow - up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin[J]. Thromb Haemost, 1995,73:356 - 361.
10[10]Wolman RL, Nussmeier NA, Aggarwal A, et al. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators[J]. Stroke,1999,30:514-522.
8Bischof D, Dallbert S, Zollinger A, et al.Thrombelastography in the surgical patients[J].Minerva Anestesiol, 2010, 76 ( 2 ) : 131-137.
9Ganter M T, Hofer C K.Coagulation monitoring current techniques and clinical use of viscoelastic point-of care coagulation devices[J].Anesth Analg, 2008, 106 (5) : 1366-1375.
